China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...
Lexicon announces PROGRESS Phase 2b study results for 10mg, 20mg
Pharmaceuticals announced topline results from the PROGRESS Phase 2b study evaluating pilavapadin, an oral, non-opioid ...
Benzinga.com2d
Best Stocks Under $20
If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...
MarketWatch1d
U.S. 20 Year Treasury Bond
Treasury yields from 7 to 30 years out trade at or above 3%, a day after Fed delivers half-point rate hike ...
autocosmos5d
Catálogo autos nuevos de MG
Encuentra el auto nuevo que estás buscando y pide una cotización a las concesionarias oficiales.